Acidophilus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo
Condition:   Lactose Intolerance Interventions:   Dietary Supplement: Lactobacillus acidophilus MPH734;   Dietary Supplement: Placebo Sponsors:   Lemuel W. Taylor IV;   Manzo Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials